Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age
NCT07823595
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
Abrocitinib
DRUG:
Placebo
Sponsor
Pfizer